---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-041877"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2022-07-27T23:59:59+00:00"
generated_at: "2026-06-24T08:17:26.460080+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve extension of business combination deadline to Nov 2022

## Summary
- Extension Proposal approved: 15,084,246 for, 1,365,812 against, 0 abstain.
- Deadline extended from Aug 6, 2022 to Nov 6, 2022, with option for monthly extensions to Feb 6, 2023.
- Proxies received for 80.4% of 20,450,000 outstanding shares, quorum present.
- Adjournment Proposal not needed due to sufficient votes for Extension Proposal.

## SEC filing metadata
- accession: 0001213900-22-041877
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2022-07-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/0001213900-22-041877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/ea163407-8k_healthsci2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-041877
- JSON: https://secwatch.observer/filing/0001213900-22-041877.json
- Plain text: https://secwatch.observer/filing/0001213900-22-041877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.